Cargando…
Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report
BACKGROUND: Sarcomatoid hepatocellular carcinoma (SHC) is a rare subtype of hepatocellular carcinoma (HCC), with a high recurrence rate after surgery. In addition to limited effective treatment for the advanced stage of SHC, the prognosis of patients with this malignancy is worse than that of patien...
Autores principales: | Zhu, Shu-Guang, Li, Hai-Bo, Yuan, Ze-Nan, Liu, Wei, Yang, Qing, Cheng, Ying, Wang, Wen-Jing, Wang, Guo-Ying, Li, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579730/ https://www.ncbi.nlm.nih.gov/pubmed/33133387 http://dx.doi.org/10.4251/wjgo.v12.i10.1209 |
Ejemplares similares
-
A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab
por: Tomioka, Masayuki, et al.
Publicado: (2021) -
Low-dose nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2022) -
Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma
por: Wang, Jian-Ping, et al.
Publicado: (2020) -
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis
por: Salati, Massimiliano, et al.
Publicado: (2018) -
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)